Restructuring Charges

6 Months Ended

Jun. 30, 2022

Restructuring Charges [Abstract]

Restructuring Charges

13.   Restructuring Charges On March 31, 2022, the Company initiated a plan to reduce its operating expenses, preserve financial resources, and focus its sales and marketing efforts on increasing utilization of CellFX Systems. The Company’s Board of Directors approved changes to the Company’s commercial leadership, restructuring of its commercial field organization and reductions in other personnel and expenses across the Company. The Company announced a reduction in force effective as of March 31, 2022. The affected employees were offered separation benefits, including severance payments along with temporary healthcare coverage assistance. The Company incurred a discrete restructuring related charge of $0.7 million which was fully recorded in March 2022 and the related expenses are included within total cost and expenses on the condensed consolidated statement of operations for the six-month period ended June 30, 2022. This charge represents the total expected amount to be incurred in connection with the activity. During the three-months ended June 30, 2022, the Company paid $0.5 million of this balance. The remaining balance of $0.2 million is recorded on the balance sheet under accrued expenses and expected to be paid throughout 2022.